Motivated, Engaged, and Organized: The New Molecular Cohorts of Lung Cancer
By D.R. Camidge
Posted: June 2018
Just as physicians and scientists no longer treat lung cancer as a single disease because of molecular distinctions, patient advocacy...
After the Consultation: Social Media, Inter-Patient Communication, and Clinical Trials
By D. R. Camidge
Posted: October 2018
Between March 2017 and April 2018, nearly 20,000 new members signed up for the Lung Cancer Survivors Support...
Lung Cancer Survivor Wins Trip to US NFL 2016 Pro Bowl
By Nicola M. Parry, DVM
Lung cancer survivor Kathy Weber is an ardent ambassador for the International Association for the Study of Lung Cancer (IASLC)....
Nursing Care’s Technological Patient-Care Transformation
By John McPhelim, RN, BSc (Hons)
Posted: March 1, 2019
Nursing—particularly communication—in lung cancer care is transforming as a result of the innovative use of supportive...
Second Annual Lung Cancer Awareness Month to Publicize Research Advances and Hope
By Keightley Amen, BA, ELS
Posted: October 2017
This November, survivors around the world will celebrate the second annual Lung Cancer Awareness Month (LCAM) Consortium. Together,...
Improving Clinical Trials Through Clinician, Patient Use of Social Media
By DR Camidge
Posted: March 1, 2019
The National Cancer Institute featured a workshop in June 2018 titled “At the Crossroads of Social Media and Clinical...
Lung Cancer Awareness Month Gathers Support and Momentum in Its Second Year
By Keightley Amen, BA, ELS
Posted: December 2017
While many people remain unaware of the advancements in the field of lung cancer and research spending still...
GLCC and IASLC Form Partnership to Explore Progress in Lung Cancer Treatment
Posted: August 22, 2019
The Global Lung Cancer Coalition (GLCC) and the IASLC have formed a partnership to explore the progress that has been made in...
Advocating for Inclusion of the Patient’s Voice
By Lori L. Alexander, MTPW, ELS, MWC
Posted: December 2017
Since 2006, the Bonnie J. Addario Lung Cancer Foundation (ALCF) has brought together a diverse group...
Letter to the Editor: Patient-Driven Research
By Jill Feldman, EGFR Resisters Co-Founder
Posted: December 11, 2019
I was so glad to see the article by Dr. Amy Moore on PDX models in the...
